SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001047469-03-020056
Filing Date
2003-05-29
Accepted
2003-05-29 16:38:16
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND, L.P.BVF INC.BVF INVESTMENTS, L.L.C.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13G a2112224zsc13ga.htm SC 13G/A 95891
3 EXHIBIT 1 a2112224zex-1.htm EX-1 12893
  Complete submission text file 0001047469-03-020056.txt   110996
Mailing Address 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405 2034888201
NEUROGEN CORP (Subject) CIK: 0000849043 (see all company filings)

IRS No.: 222845714 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-41776 | Film No.: 03723825
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 W MONROE SUITE 4800 CHICAGO IL 60606
Business Address ONE SANSOME ST 39TH FL SAN FRANCISCO CA 94104 3122637777
BVF PARTNERS L P/IL (Filed by) CIK: 0001055947 (see all company filings)

IRS No.: 363924730